Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · Real-Time Price · USD
17.11
-1.20 (-6.55%)
At close: Sep 11, 2026, 4:00 PM EDT
17.21
+0.10 (0.58%)
After-hours: Sep 11, 2026, 7:46 PM EDT

Tandem Diabetes Care Revenue

Tandem Diabetes Care had revenue of $254.56M in the quarter ending June 30, 2026, with 5.77% growth. This brings the company's revenue in the last twelve months to $1.04B, up 3.96% year-over-year. In the year 2025, Tandem Diabetes Care had annual revenue of $1.01B with 7.93% growth.

Revenue (ttm)
$1.04B
Revenue Growth
+3.96%
P/S Ratio
1.14
Revenue / Employee
$416,567
Employees
2,500
Market Cap
1.19B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.01B74.53M7.93%
Dec 31, 2024940.20M192.49M25.74%
Dec 31, 2023747.72M-53.50M-6.68%
Dec 31, 2022801.22M98.42M14.00%
Dec 31, 2021702.80M203.97M40.89%
Dec 31, 2020498.83M136.53M37.68%
Dec 31, 2019362.31M178.44M97.05%
Dec 31, 2018183.87M76.27M70.88%
Dec 31, 2017107.60M23.35M27.72%
Dec 31, 201684.25M11.40M15.65%
Dec 31, 201572.85M23.13M46.51%
Dec 31, 201449.72M20.72M71.41%
Dec 31, 201329.01M26.53M1,072.00%
Dec 31, 20122.48M--
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Enovis2.30B
Integra LifeSciences Holdings1.65B
CONMED1.37B
Lumexa Imaging Holdings1.04B
Alphatec Holdings815.05M
NovoCure699.19M
Bioventus581.85M
Artivion471.47M
Revenue Rankings